These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 130147)

  • 1. Further purification of the lymphocyte inhibiting extract from the thymus.
    Kiger N; Florentin I; Mathe G
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):244-9. PubMed ID: 130147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).
    Kiger N; Florentin I; Lorans G; Mathe G
    Immunology; 1977 Oct; 33(4):439-48. PubMed ID: 924515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lymphocyte-inhibiting factor (chalone?) extracted from thymus: immunosuppressive effects.
    Kiger N; Florentin I; Mathé G
    Natl Cancer Inst Monogr; 1973 Jul; 38():135-42. PubMed ID: 4271036
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical and biological properties of a thymocyte specific growth factor from calf thymus.
    Söder O; Ernström U
    Thymus; 1981 Nov; 3(4-5):289-305. PubMed ID: 6976028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte specificity of a lymphocyte-inhibiting factor (chalone) extracted from the thymus.
    Florentin I; Kiger N; Mathé G
    Eur J Immunol; 1973 Oct; 3(10):624-7. PubMed ID: 4271832
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous factors possessing lymphoid chalone properties, purified by chromatography.
    Privat de Garilhe M; Vedel M; Tempête C; Federici C; Garcia-Giralt E
    Biomedicine; 1980 Oct; 32(3):148-54. PubMed ID: 6449966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymus-derived inhibitor of lymphocyte proliferation. II. Tissue specificity in vitro and in vivo.
    Rijke EO; Lempers HC; Ballieux RE
    Cell Tissue Kinet; 1981 Jan; 14(1):31-8. PubMed ID: 6451295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for specific calf thymus inhibitors (chalones) of T-lymphocyte proliferation.
    Maschler R; Maurer HR
    Hoppe Seylers Z Physiol Chem; 1979 Jun; 360(6):735-45. PubMed ID: 157318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-derived immunosuppressive substances. II. An evaluation of various sources for an endogenous regulator of lymphocyte activation.
    Miller F; Habicht GS
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):228-38. PubMed ID: 22495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte inhibitory factors (chalones) extracted from lymphoid organs. Extraction, partial purification and immunosuppressive properties.
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Transplant Proc; 1972 Dec; 4(4):531-6. PubMed ID: 4264869
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro production of lymphocyte and granulocyte proliferation inhibitors (chalones?) from living cells.
    Maiolo AT; Cazzaniga E; Cortelezzi A; De Pangher V; Foa P; Lombardi L; Mozzana R; Polli EE
    Boll Ist Sieroter Milan; 1975 Jul; 54(3):235-43. PubMed ID: 130146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic factors regulating DNA synthesis in lymphocytes cultured in vitro.
    Ernström U; Nordlind K
    Int Arch Allergy Appl Immunol; 1977; 54(5):463-72. PubMed ID: 885630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecular mass inhibitor of growth of MDCK cells derived from pig spinal cord.
    Emoto Y; Kawahara E; Koga Y; Ito T; Tawada K
    J Cell Physiol; 2001 Mar; 186(3):350-6. PubMed ID: 11169973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a low-molecular-weight growth inhibitory factor from hybridoma cell cultures.
    Røe O; Brondz I; Rønning OW; Nissen-Meyer J
    Biochem Biophys Res Commun; 1999 Jan; 254(1):138-42. PubMed ID: 9920746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight into lymphocytic chalone research. The 'facteur thymique Sérique' might be responsible for part of the immunosuppressive activity detected in the 'chalone fraction'.
    Lenfant M; Millerioux L
    Int Arch Allergy Appl Immunol; 1982; 68(4):387-91. PubMed ID: 6212552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New preparative schedule and further characterization of a thymocyte specific growth factor from calf thymus.
    Söder O; Ernström U
    Int Arch Allergy Appl Immunol; 1983; 72(2):134-8. PubMed ID: 6874108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is thymus-derived lymphocyte inhibitor a polyamine?
    Rijke EO; Ballieux RE
    Nature; 1978 Aug; 274(5673):804-5. PubMed ID: 150541
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymic stromal cells produce inhibitors of proliferation of thymic, but not splenic T cells.
    Kinohara N; Makinodan T
    Thymus; 1987; 10(3-4):179-92. PubMed ID: 3501183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some in vivo effects of chalone (mitotic inhibitor) obtained from lymphoid tissues.
    Chung AC; Hufnagel CA
    Natl Cancer Inst Monogr; 1973 Jul; 38():131-4. PubMed ID: 4271035
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological specificity of low molecular weight inhibitors of lymphocyte transformation.
    Patt LM; Barrantes DM; Houck JC
    Pharmacology; 1982; 24(2):74-81. PubMed ID: 6210916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.